This website uses cookies to enhance the user experience.
V

VISTIN PHARMA ASA915 157 882

Process industry
Public limited company
Østensjøveien 27 0661 OSLO, Norge

VISTIN PHARMA ASA

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Links

Organization

Chairman of the board
Years since formation
9 years
since Mar 24, 2015
Type
Public limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
44,344,592
1 share class
Total number of shareholders
2012
195 companies, 1,817 persons
Belongs to group of

Financials

Annual total result 2023
-2,984,000
NOK
Total equity 2023
265,148,000
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman
9.65 %
indirectly
Board Member
3.61 %
directly 0.73 %
indirectly 2.88 %
ÅM
Board Member-
Board Member-
Board Member-
Board Member-
Board Member-
Alternate Member-
Alternate Member-
Alternate Member-
Alternate Member-
Observer-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Chairman
9.65 %
indirectly
-
9.35 %
indirectly
-
9.35 %
indirectly
Board Member
3.61 %
directly 0.73 %
indirectly 2.88 %
-
2.02 %
indirectly
-
1.83 %
indirectly
-
1.76 %
directly 0.07 %
indirectly 1.69 %
-
1.67 %
directly 0.05 %
indirectly 1.62 %
-
1.36 %
directly
-
1.2 %
directly 0.23 %
indirectly 0.97 %
Last update: Jun 4, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
I
INTERTRADE SHIPPING AS
NO0010734122
12,575,000
28.36 %
H
HOLMEN SPESIALFOND
NO0010734122
3,842,055
8.66 %
P
PACTUM VEKST AS
NO0010734122
3,519,733
7.94 %
M
MP PENSJON PK
NO0010734122
1,719,848
3.88 %
F
FERNCLIFF LISTED DAI AS
NO0010734122
1,234,280
2.78 %
S
STORKLEIVEN AS
NO0010734122
751,000
1.69 %
A
AUGUST RINGVOLD AGENTUR AS
NO0010734122
750,315
1.69 %
L
LUCELLUM AS
NO0010734122
720,000
1.62 %
NO0010734122
601,516
1.36 %
I
IVAR LØGES STIFTELSE
NO0010734122
550,000
1.24 %
NO0010734122
526,324
1.19 %
C
CORTEX AS
NO0010734122
508,989
1.15 %
W
WEM INVEST AS
NO0010734122
500,000
1.13 %
NO0010734122
478,860
1.08 %
S
SANDEN EQUITY AS
NO0010734122
468,947
1.06 %
D
DELTA AS
NO0010734122
410,000
0.92 %
G
GINKO AS
NO0010734122
400,000
0.9 %
NO0010734122
323,650
0.73 %
NO0010734122
301,658
0.68 %
NO0010734122
284,040
0.64 %
M
MIKLA INVEST AS
NO0010734122
276,132
0.62 %
S
SOGNEFJELL AS
NO0010734122
264,291
0.6 %
M
MELESIO INVEST AS
NO0010734122
259,808
0.59 %
F
FRENICO AS
NO0010734122
215,000
0.48 %
H
HJELLEGJERDE INVEST AS
NO0010734122
200,000
0.45 %
O
OVÅ INVEST AS
NO0010734122
200,000
0.45 %
T
TRULS INVEST AS
NO0010734122
200,000
0.45 %
NO0010734122
200,000
0.45 %
N
NORUMBEGA AS
NO0010734122
200,000
0.45 %
J
JOTUNFJELL AS
NO0010734122
200,000
0.45 %
F
Fraternitas A/S
NO0010734122
180,000
0.41 %
T
TRACK AS
NO0010734122
179,087
0.4 %
NO0010734122
160,112
0.36 %
NO0010734122
155,524
0.35 %
H
HEKAMA INVEST AS
NO0010734122
153,440
0.35 %
E
EMKAY INVEST AS
NO0010734122
150,000
0.34 %
NO0010734122
140,000
0.32 %
A
AGDES INVEST AS
NO0010734122
138,500
0.31 %
G
GSH INVEST AS
NO0010734122
131,000
0.3 %
N
NORDNET LIVSFORSIKRING AS
NO0010734122
130,282
0.29 %
F
FOLLUM CAPITAL AS
NO0010734122
128,000
0.29 %
NO0010734122
125,000
0.28 %
NO0010734122
124,667
0.28 %
NO0010734122
120,093
0.27 %
A
AALL KAPITAL AS
NO0010734122
115,262
0.26 %
NO0010734122
115,003
0.26 %
G
GK INVEST HOLDING AS
NO0010734122
115,000
0.26 %
NO0010734122
107,874
0.24 %
B
B SKAUGEN AS
NO0010734122
101,176
0.23 %
L
LUUNA AS
NO0010734122
100,264
0.23 %
V
VITAMAR AS
NO0010734122
100,000
0.23 %
NO0010734122
100,000
0.23 %
S
SAGA PURE ASA
NO0010734122
100,000
0.23 %
B
BELE AS
NO0010734122
100,000
0.23 %
F
FATEBURET AS
NO0010734122
100,000
0.23 %
B
BELA AS
NO0010734122
100,000
0.23 %
H
HAFSTAD INVEST AS
NO0010734122
96,000
0.22 %
NO0010734122
95,000
0.21 %
NO0010734122
94,800
0.21 %
NO0010734122
87,793
0.2 %
H
HARMOHNI AS
NO0010734122
85,000
0.19 %
K
KULA INVEST AS
NO0010734122
84,850
0.19 %
NO0010734122
81,200
0.18 %
NO0010734122
80,000
0.18 %
NO0010734122
77,360
0.17 %
M
MUSTADGÅRDENE HOLDING AS
NO0010734122
76,307
0.17 %
C
CHRISHØEG AS
NO0010734122
75,875
0.17 %
NO0010734122
75,000
0.17 %
M
MAGNUS DEN GODE AS
NO0010734122
73,000
0.16 %
NO0010734122
71,000
0.16 %
T
TRINITY GROUP AS
NO0010734122
70,000
0.16 %
NO0010734122
69,000
0.16 %
NO0010734122
65,700
0.15 %
NO0010734122
64,274
0.14 %
NO0010734122
62,000
0.14 %
A
ALF MARTINSEN INVEST AS
NO0010734122
60,000
0.14 %
M
MARTIN AS
NO0010734122
60,000
0.14 %
A
AASHEIM INVEST AS
NO0010734122
60,000
0.14 %
U
UNIVERSAL EXPORTS AS
NO0010734122
60,000
0.14 %
NO0010734122
60,000
0.14 %
NO0010734122
60,000
0.14 %
NO0010734122
59,051
0.13 %
A
AEL INVEST AS
NO0010734122
55,000
0.12 %
NO0010734122
53,109
0.12 %
NO0010734122
53,031
0.12 %
NO0010734122
52,995
0.12 %
G
GAIN AS
NO0010734122
51,335
0.12 %
NO0010734122
50,120
0.11 %
NO0010734122
50,000
0.11 %
NO0010734122
50,000
0.11 %
NO0010734122
50,000
0.11 %
NO0010734122
50,000
0.11 %
NO0010734122
50,000
0.11 %
O
ORAKEL AS
NO0010734122
50,000
0.11 %
V
VALSET INVEST AS
NO0010734122
50,000
0.11 %
L
LAL HOLDING AS
NO0010734122
50,000
0.11 %
A
AASE INVESTERING AS
NO0010734122
50,000
0.11 %
NO0010734122
49,725
0.11 %
N
NIRA AS
NO0010734122
49,000
0.11 %
NO0010734122
45,000
0.1 %

Shares owned by the VISTIN PHARMA ASA

NameShare classNumber of sharesShare
V
VISTIN PHARMA AS
Ordinary shares
50,000
100 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -6,978,000
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
-2,984,000
-1,852,000
-2,558,000
Total assets
266,244,000
269,084,000
277,810,000
Total liabilities
1,096,000
953,000
7,829,000
Total equity
265,148,000
268,132,000
269,983,000

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
6,978,000
4,194,000
4,698,000
Operating result
-6,978,000
-4,194,000
-4,698,000
Financial income/costs
3,152,000
1,820,000
1,419,000
Profit before tax
-3,826,000
-2,374,000
-3,279,000
Total tax & extraordinary income/cost
-842,000
-522,000
-721,000
Annual Total Result
-2,984,000
-1,852,000
-2,558,000

Balance overview

Year202320222021
Total fixed assets
113,113,000
108,112,000
107,590,000
Total current assets
153,131,000
160,972,000
170,220,000
Total assets
266,244,000
269,084,000
277,810,000
Short term debt
1,096,000
953,000
7,829,000
Long term debt
0
0
0
Total liabilities
1,096,000
953,000
7,829,000
Contributed capital
265,148,000
268,132,000
269,983,000
Retained earnings
0
0
0
Total equity
265,148,000
268,132,000
269,983,000
Total equity and liabilities
266,244,000
269,085,000
277,812,000

Classification

Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations